Funding search · EIN 237002878 · Los Angeles, CA

Concern Foundation

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

61
grants reported
$3.5M
total given
2022–2024
filing years
$60,000
median grant

Based on grants this organization reported to the IRS for tax years 20222024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

cancertumorcelltargetingnovelpancreaticbreastcells

Funder website ↗Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

5 grants matching “metastatic · $495,000

  • $75,000

    Temple University · Philadelphia, PA · 2024

    Role of chemotherapy in promoting awakening of dormant tumor cells and metastatic relapse

  • $75,000

    The Wistar Institute · Philadelphia, PA · 2024

    Myeloid cell-derived interleukin 1b promotes chemoresistance in metastatic ovarian cancer.

  • $225,000

    Children'S Hospital Los Angeles Usc · Los Angeles, CA · 2023

    Flip-flopping of fusion-positive rhabdomyosarcoma leading to metastatic invasion

  • $60,000

    Children'S Hospital Los Angeles Usc · Los Angeles, CA · 2023

    Flip-flopping of fusion-positive rhabdomyosarcoma leading to metastatic invasion

  • $60,000

    Children'S Hospital Los Angeles Usc · Los Angeles, CA · 2022

    Flip-flopping of fusion-positive rhabdomyosarcoma leading to metastatic invasion

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

  • Children'S Hospital Los Angeles Usc3 grants · $345,000
  • University of Southern California5 grants · $338,500
  • Children'S Hospital Los Angeles4 grants · $215,000
  • Beckman Research Institute of City of Hope3 grants · $170,000
  • Childrens Hospital Los Angeles1 grant · $150,000
  • Usc Norris Comprehensive Cancer Center2 grants · $125,000
  • Washington University School of Medicine in St Louis2 grants · $120,000
  • Brigham and Women'S Hospitalharvard Medical School2 grants · $120,000
  • Nyu Grossman School of Medicine2 grants · $120,000
  • Purdue University2 grants · $120,000

Giving over time

$925,000
2022
$1.2M
2023
$1.4M
2024

Grant history

All 61 reported grants, largest first.

  • $225,000

    Children'S Hospital Los Angeles Usc · Los Angeles, CA · 2023

    Flip-flopping of fusion-positive rhabdomyosarcoma leading to metastatic invasion

  • $150,000

    Childrens Hospital Los Angeles · Los Angeles, CA · 2024

    Novel molecular mechanism(s) of p1d1 function in pediatric brain tumors.

  • $100,000

    Usc Norris Comprehensive Cancer Center · Los Angeles, CA · 2024

    Ethnic differences in immune responses among breast cancer patients

  • $100,000

    University of Southern California · Los Angeles, CA · 2023

    Ethnic differences among breast cancer patient immune responses

  • $100,000

    University of Southern California · Los Angeles, CA · 2022

    Research into ethnic differences among breast cancer patient immune responses

  • $90,000

    Children'S Hospital Los Angeles · Los Angeles, CA · 2024

    Summer oncology research fellowship program

  • $75,000

    Children'S Hospital Los Angeles · Los Angeles, CA · 2024

    Elucidating the mechanism of chromosome 17q gain-mediated neuroblastoma tumorigenesis

  • $75,000

    Memorial Sloan Kettering Cancer Center · New York, NY · 2024

    Early transcriptional, epigenetic, and environmental factors of squamous transformation in lung cancer

  • $75,000

    Ohio State University · Columbus, OH · 2024

    Targeting a new immune checkpoint axis (pilrcd8) to treat glioblastoma

  • $75,000

    Oregon Health & Science University · Portland, OR · 2024

    Antigen sorting by dendritic cells impacts anti-tumor immunity

  • $75,000

    Oregon Health and Science University · Portland, OR · 2024

    Reprogramming suppressive regulatory t cells in the tumor microenvironment

  • $75,000

    Temple University · Philadelphia, PA · 2024

    Role of chemotherapy in promoting awakening of dormant tumor cells and metastatic relapse

  • $75,000

    The University of Texas Md Anderson Cancer Center · Houston, TX · 2024

    Targeting collagen i homotrimer induced il-18 as a novel therapeutic strategy in pancreatic cancer

  • $75,000

    The Wistar Institute · Philadelphia, PA · 2024

    Myeloid cell-derived interleukin 1b promotes chemoresistance in metastatic ovarian cancer.

  • $75,000

    Ut Md Anderson Cancer Center · Houston, TX · 2024

    Elucidating the molecular and cellular pathogenesis of endogenous retroviruses in skin cancer

  • $75,000

    Washington University · St Louis, MO · 2024

    Targeting mechanisms of tumor immune evasion in cervical cancer

  • $60,000

    Beckman Research Institute of City of Hope · Duarte, CA · 2023

    Targeting the long isoform of the prolactin receptor in b cell malignancies

  • $60,000

    Brigham and Women'S Hospitalharvard Medical School · Boston, MA · 2023

    Overcoming parp inhibitor resistance by modulating tumor associated macrophages to enhance t cell activation

  • $60,000

    Children'S Hospital Los Angeles Usc · Los Angeles, CA · 2023

    Flip-flopping of fusion-positive rhabdomyosarcoma leading to metastatic invasion

  • $60,000

    Nyu Grossman School of Medicine · Ny, NY · 2023

    Discovering and targeting coq10 synthesis in pancreatic cancer

  • $60,000

    Purdue University · West Lafayette, IN · 2023

    The role of pp2a in regulating pdac methuosis

  • $60,000

    The Lundquist Institute at Harbor-UCLA Medical Center · Torrance, CA · 2023

    Investigating novel signaling circuits controlling pdl1 surface localization in cancer cells.

  • $60,000

    The University of Illinois at Chicago · Chicago, IL · 2023

    Regulation of mechanosurveillance by k handling during breast cancer metastasis

  • $60,000

    University of Michigan · Ann Arbor, MI · 2023

    Regulating jak-stat signaling pathways to enhance t cell immunotherapy

  • $60,000

    University of Southern California · Los Angeles, CA · 2023

    Expansion of the adolescent and young adult cancer program at usc

  • $60,000

    University of Utah · Salt Lake City, UT · 2023

    Tenascin-c in early lung cancer invasion

  • $60,000

    Washington University School of Medicine in St Louis · St Louis, MO · 2023

    Investigate the tumor suppressive role of arid homologs in melanoma

  • $60,000

    Beckman Research Institute of City of Hope · Duarte, CA · 2022

    Targeting the long isoform of the prolactin receptor in b cell malignancies

  • $60,000

    Brigham and Women'S Hospitalharvard Medical School · Boston, MA · 2022

    Overcoming parp inhibitor resistance by modulating tumor associated macrophages to enhance t cell activation

  • $60,000

    Children'S Hospital Los Angeles Usc · Los Angeles, CA · 2022

    Flip-flopping of fusion-positive rhabdomyosarcoma leading to metastatic invasion

  • $60,000

    Medical University of South Carolina · Charleston, SC · 2022

    Krasg12r allele-specific metabolic reprogramming alters therapeutic sensitivity

  • $60,000

    Nyu Grossman School of Medicine · New York, NY · 2022

    Discovering and targeting coq10 synthesis in pancreatic cancer

  • $60,000

    Purdue University · West Lafayette, IN · 2022

    The role of pp2a in regulating pdac methuosis

  • $60,000

    The Lundquist Institute at Harbor-UCLA Medical Center · Torrance, CA · 2022

    Investigating novel signaling circuits controlling pdl1 surface localization in cancer cells.

  • $60,000

    The University of Illinois at Chicago · Chicago, IL · 2022

    Regulation of mechanosurveillance by k handling during breast cancer metastasis

  • $60,000

    University of Michigan · Ann Arbor, MI · 2022

    Regulating jak-stat signaling pathways to enhance t cell immunotherapy

  • $60,000

    University of Utah · Salt Lake City, UT · 2022

    Tenascin-c in early lung cancer invasion

  • $60,000

    Washington University School of Medicine in St Louis · St Louis, MO · 2022

    Investigate the tumor suppressive role of arid homologs in melanoma

  • $55,000

    University of Southern California · Los Angeles, CA · 2022

    Liquid biopsy database creation

  • $50,000

    U-Grow Program Cedars Sinai Medical Center · Los Angeles, CA · 2024

    For the u grow program preparing future scientists for graduate school

  • $50,000

    Cedars Sinai · Los Angeles, CA · 2023

    U-grow program

  • $50,000

    Beckman Research Institute of City of Hope · Duarte, CA · 2022

    Disrupting metabolic adaptation in pancreatic cancer through intratumoral heparan sulfate degradatior

  • $45,000

    Beauty Bus Foundation · Los Angeles, CA · 2024

    Pop-up events for the cancer community

  • $30,000

    Hope for Henry Foundation · Washington, DC · 2024

    To expand the hope for henrys high-impact and in-demand super rewards for super kids program to one new hospital.

  • $25,000

    Children'S Hospital Los Angeles · Los Angeles, CA · 2024

    Evaluation of a novel cellular therapy for children and young adolescents with high-grade glioma brain tumors

  • $25,000

    Sharsheret · Los Angeles, CA · 2024

    To cover busy box and thriving again kits

  • $25,000

    Urologic Health Program Providence St Joseph'S Medical Center Disney Famil · Burbank, CA · 2024

    To cover urologic oncology programs at the disney cancer center

  • $25,000

    Usc Norris Comprehensive Cancer Center · Los Angeles, CA · 2024

    To expand the adolescent and young adult cancer program at usc

  • $25,000

    Usc Norris Head & Neck Cancer · Los Angeles, CA · 2024

    To support a novel head and neck squamous cell carcinoma (hnscc) immunotherapy study using both animal models and patient-derived tumor organoids

  • $25,000

    Chla Summer Oncology · Los Angeles, CA · 2023

    Summer oncology research fellowship

  • $25,000

    Providence · Burbank, CA · 2023

    Urologic oncology programs at the disney cancer center

  • $25,000

    Sharsheret · Teaneck, NJ · 2023

    Busy box and thriving again kits

  • $25,000

    Children'S Hospital Los Angeles · Los Angeles, CA · 2022

    Summer student oncology program

  • $25,000

    Sharsheret · Teaneck, NJ · 2022

    Quality of life kits and the busy boxes

  • $23,500

    University of Southern California · Los Angeles, CA · 2023

    Expansion of the adolescent and young adult cancer program at usc

  • $22,000

    City of Hope · Duarte, CA · 2024

    Pancreatic ductal adenocarcinoma- collecting plasma with pancreatic cancer and those in high risk of developing the disease

  • $20,000

    Cedars Sinai Medical Center · Los Angeles, CA · 2024

    To cover services and workshops for the wellness, resilience, and survivorship program

  • $20,000

    Cedars Sinai · Los Angeles, CA · 2023

    Wellness, resilience, and survivorship program

  • $10,000

    Hope for Henry Foundation · Washington, DC · 2022

    Super rewards for super kids at chla

  • $9,000

    City of Hope · Duarte, CA · 2023

    Pancreatic ductal adenocarcinoma- collecting plasma with pancreatic cancer and those in high risk of developing the disease

  • $2,281

    Hope for Henry · Washington, DC · 2023

    Expansion of the hope for henrys high-impact and in-demand super rewards for super kids program to one new hospital

Who else funds this kind of work

Same state

Similar purposes

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.